Logo image
Se connecter
Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study
Article de revue   Avec comité de lecture

Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study

Pauline Houssel-Debry, Audrey Coilly, Claire Fougerou-Leurent, Caroline Jezequel, Christophe Duvoux, Victor Ledinghen, Sylvie Radenne, Nassim Kamar, Vincent Leroy, Vincent Di Martino, …
Hepatology (Baltimore, Md.), Vol.63(1 SUPP), pp.465A-465A
2017

Résumé

Life Sciences
Meeting Abstract: 925

Indicateurs

1 Consultations de la notice

Détails

Logo image